Effects of endocannabinoid system modulation on cognitive and emotional behavior

Zanettini, Claudio·2011·Frontiers in Behavioral Neuroscience

Cited by (215)

Items 101–200 of 215

  1. Synaptic plasticity in schizophrenia pathophysiology
    Kexuan Zhang, Panlin Liao, Jin Wen, Zhonghua Hu · 2023 · IBRO Neuroscience Reports
  2. The effects of intermittent theta burst stimulation (iTBS) on resting-state brain entropy (BEN)
    P. Liu, Donghui Song, Xin‐Ping Deng, Yuanqi Shang, Qiu Ge, Ze Wang, Hui Zhang · 2025 · Neurotherapeutics
  3. Involvement of the nucleus accumbens shell glutamatergic system in ACPA-induced impairment of inhibitory avoidance memory consolidation
    Khalil Rasekhi, Shahrbanoo Oryan, Mohammad Nasehi, Mohammad‐Reza Zarrindast · 2014 · Behavioural Brain Research
  4. Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging
    Ana C. Pascual, Virginia L. Gaveglio, Norma Maria Giusto, Susana J. Pasquaré · 2014 · Experimental Gerontology
  5. Interactions of CB1 and mGlu5 receptor antagonists in food intake, anxiety and memory models in rats
    Balázs Varga, Ferenc Kassai, István Gyertyán · 2012 · Pharmacology Biochemistry and Behavior
  6. Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB 1 or CB 2 agonists
    Jessica Brandi, Ilaria Dando, Marta Palmieri, Massimo Donadelli, Daniela Cecconi · 2013 · Electrophoresis
  7. Cannabinoids in Health and Disease
    Rosaria Meccariello, Rosanna Chianese · 2016 · InTech eBooks
  8. Acute acetaminophen intoxication induces direct neurotoxicity in rats manifested as astrogliosis and decreased dopaminergic markers in brain areas associated with locomotor regulation
    María Belén Vigo, María Julia Pérez, Fernanda De Fino, Gimena Gómez, Sonia Amalia Martinez, Verónica Bisagno, María Beatriz Di Carlo, Alejandra Scazziota, José Enrique Manautou, Carolina Inés Ghanem · 2019 · Biochemical Pharmacology
  9. Cannabinoid drugs against chemotherapy-induced adverse effects: focus on nausea/vomiting, peripheral neuropathy and chemofog in animal models
    Ana Bagüés, Yolanda López‐Tofiño, Alvaro Llorente‐Berzal, Raquel Abalo · 2022 · Behavioural Pharmacology
  10. Role of the cannabinoid CB1 receptor in methamphetamine-induced social and recognition memory impairment
    Mehdi Khodamoradi, Fatemeh Tirgar, Hamed Ghazvini, Raheleh Rafaiee, Seyedeh Masoumeh Seyedhosseini Tamijani, Narges Karimi, Ali Yadegari, Ali Siahposht-Khachaki, Javad Akhtari · 2022 · Neuroscience Letters
  11. Emerging roles of cannabinoid receptor CB2 receptor in the central nervous system: therapeutic target for CNS disorders
    Kanchan Bala, Pratyush Porel, Khadga Raj Aran · 2024 · Psychopharmacology
  12. Blunting of the HPA-axis underlies the lack of preventive efficacy of early post-stressor single-dose Delta-9-tetrahydrocannabinol (THC)
    Tzur Alexander Mayer, Michael Alex Matar, Zeev Kaplan, Joseph Zohar, Hagit Cohen · 2014 · Pharmacology Biochemistry and Behavior
  13. Plasma and interstitial levels of endocannabinoids and N-acylethanolamines in patients with chronic widespread pain and fibromyalgia: a systematic review and meta-analysis
    Inna Kurlyandchik, Romy Lauche, Evelin Tiralongo, Leon N. Warne, Janet Margaret Schloss · 2022 · PAIN Reports
  14. Behavioural and pharmacological characterization of a novel cannabinomimetic adamantane-derived indole, APICA, and considerations on the possible misuse as a psychotropic spice abuse, in C57bl/6J MICE
    Cannizzaro, Carla, Malta, Ginevra, Argo, Antonina, Brancato, Anna, Roda, Gabriella, Casagni, Eleonora, Fumagalli, Laura, Valoti, Ermanno, Froldi, Rino, Procaccianti, Paolo et al. · 2016 · Forensic Science International
  15. Anxiety Modulation by Cannabinoids—The Role of Stress Responses and Coping
    József Haller · 2023 · International Journal of Molecular Sciences
  16. Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention?
    Yannick Marchalant, Kévin Baranger, Gary L. Wenk, Michel Khrestchatisky, Santiago Rivera · 2012 · Journal of Neuroinflammation
  17. Δ9-tetrahydrocannabinol modulates the proteasome system in the brain
    Victòria Salgado-Mendialdúa, Joaquim Aguirre‐Plans, Emre Güney, Rita Reig‐Viader, Rafael J. Maldonado, Àlex Bayés, Baldomero Oliva, Andrés Ozaita · 2018 · Biochemical Pharmacology
  18. Interactions of Noradrenergic, Glucocorticoid and Endocannabinoid Systems Intensify and Generalize Fear Memory Traces
    Lucas Gazarini, Cristina Aparecida Jark Stern, Reinaldo Naoto Takahashi, Leandro Jose Bertoglio · 2021 · Neuroscience
  19. Impact of Embedded Endocannabinoids and Their Oxygenation by Lipoxygenase on Membrane Properties
    Enrico Dainese, Annalaura Sabatucci, Clotilde Beatrice Angelucci, Daniela Barsacchi, Marco Chiarini, Mauro Maccarrone · 2012 · ACS Chemical Neuroscience
  20. Peripheral CB1 receptor blockade acts as a memory enhancer through a noradrenergic mechanism
    Sara Martínez‐Torres, Araceli Bergadà‐Martínez, Jorge Emilio Ortega, Lorena Galera-López, Arnau Hervera, Lucía de los Reyes‐Ramírez, Antonio Ortega-Álvaro, Floortje Remmers, Emma Muñoz‐Moreno, Guadalupe Sòria et al. · 2022 · Neuropsychopharmacology
  21. Prolonged cannabis withdrawal in young adults with lifetime psychiatric illness
    Randi Melissa Schuster, Madeleine Fontaine, Emily Nip, Haiyue Zhang, Ailish M. Hanly, Anne Eden Evins · 2017 · Preventive Medicine
  22. Endocannabinoid markers in autism spectrum disorder: A scoping review of human studies
    Michelle De Pol, Nathan J. Kolla · 2021 · Psychiatry Research
  23. Implications of the endocannabinoid system and the therapeutic action of cannabinoids in autism spectrum disorder: A literature review
    Rick Wilhiam de Camargo, Linério Ribeiro de Novais Júnior, Larissa Mendes da Silva, Vicente Meneguzzo, Guilherme Cabreira Daros, Marina Goulart da Silva, Rafael Mariano de Bitencourt · 2022 · Pharmacology Biochemistry and Behavior
  24. Involvement of 2-arachidonoylglycerol signaling in social challenge responding of male CD1 mice
    Manó Aliczki, Zoltán Kristóf Varga, Zoltan Balogh, József Haller · 2014 · Psychopharmacology
  25. Endocannabinoid interactions in the regulation of acquisition of contextual conditioned fear
    Zoltan Balogh, László Szente, László Bíró, Zoltán Kristóf Varga, József Haller, Manó Aliczki · 2018 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  26. Providing a food reward reduces inhibitory avoidance learning in zebrafish
    Remy Manuel, Jan Zethof, Gert Flik, Ruud van den Bos · 2015 · Behavioural Processes
  27. In vivo Evidence for Brain Region-Specific Molecular Interactions Between Cannabinoid and Orexin Receptors
    Hye Ji J. Kim, Ayat Zagzoog, Anna-Maria Smolyakova, Udoka C. Ezeaka, Michael J. Benko, Teagan Holt, Robert B. Laprairie · 2021 · Frontiers in Neuroscience
  28. RETRACTED: Anandamide mediates cognitive judgement bias in rats
    Jakub Kregiel, Natalia Małek, Piotr Popik, Katarzyna Starowicz, Rafał Ryguła · 2015 · Neuropharmacology · Retracted
  29. Effects of cannabis use and subclinical depression on the P3 event-related potential in an emotion processing task
    Lucy J. Troup, Robert D. Torrence, Jeremy A. Andrzejewski, Jacob T. Braunwalder · 2017 · Medicine
  30. Pharmacological inhibition of the CB1 cannabinoid receptor restores abnormal brain mitochondrial CB1 receptor expression and rescues bioenergetic and cognitive defects in a female mouse model of Rett syndrome
    Livia Cosentino, Chiara Urbinati, Chiara Lanzillotta, Domenico De Rasmo, Daniela Valenti, Mattia Pellas, Maria Cristina Quattrini, Fabiana Piscitelli, Magdalena Kostrzewa, Fabio Di Domenico et al. · 2024 · Molecular Autism
  31. Cannabinoid receptor gene CNR1 is downregulated in subcortical brain samples and upregulated in blood samples of individuals with schizophrenia: A participant data systematic meta‐analysis
    Stav Bloch Priel, Assif Yitzhaky, David Gurwitz, Libi Hertzberg · 2023 · European Journal of Neuroscience
  32. The effects anandamide signaling in the prelimbic cortex and basolateral amygdala on coping with environmental stimuli in rats
    Manó Aliczki, István Barna, Ibolya Till, Mária Baranyi, Beáta Sperlágh, Steven R. Goldberg, József Haller · 2016 · Psychopharmacology
  33. The association between cannabis use and facial emotion recognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study
    Laura Fusar‐Poli, Lotta-Katrin Pries, Jim van Os, Rajiv Radhakrishnan, Aysegul Yay-Pence, Gamze Erzın, Philippe Delespaul, Günter Kenis, Jurjen Justin Luykx, Bochao Danae Lin et al. · 2022 · European Neuropsychopharmacology
  34. Interaction between hippocampal serotonin and cannabinoid systems in reactivity to spatial and object novelty detection
    Nasehi, Mohammad, Rostam-Nezhad, Elnaz, Ebrahimi-Ghiri, Mohaddeseh, Zarrindast, Mohammad-Reza · 2017 · Behavioural Brain Research
  35. Molecular and cellular mechanisms underlying brain region-specific endocannabinoid system modulation by estradiol across the rodent estrus cycle
    Hye Ji J. Kim, Ayat Zagzoog, Tallan Black, Sarah L. Baccetto, Robert B. Laprairie · 2022 · Progress in molecular biology and translational science
  36. Cannabinoid Receptor 1 Agonist ACEA and Cannabinoid Receptor 2 Agonist GW833972A Attenuates Cell-Mediated Immunity by Different Biological Mechanisms
    Nuchjira Takheaw, Kanyaruck Jindaphun, Supansa Pata, Witida Laopajon, Watchara Kasinrerk · 2023 · Cells
  37. UK Medical Cannabis Registry: An analysis of clinical outcomes of medicinal cannabis therapy for attention‐deficit/hyperactivity disorder
    Pim Ittiphakorn, Simon Erridge, Carl Holvey, Ross Coomber, James Rucker, Mikael Hans Sodergren · 2023 · Neuropsychopharmacology Reports
  38. PAK1 regulates inhibitory synaptic function via a novel mechanism mediated by endocannabinoids
    Shuting Xia, Zikai Zhou, Zhengping Jia · 2016 · Small GTPases
  39. The cannabis paradox: when age matters
    Andrés Ozaita, Ester Aso · 2017 · Nature Medicine
  40. Social Factors and Animal Models of Cannabis Use
    Lauren E. Hood · 2018 · International review of neurobiology
  41. Associations Among Parental Caregiving Quality, Cannabinoid Receptor 1 Expression-Based Polygenic Scores, and Infant-Parent Attachment: Evidence for Differential Genetic Susceptibility?
    Amelia Potter-Dickey, Nicole Lyn Letourneau, Patrícia Pelufo Silveira, Henry N. Ntanda, Gerald F. Giesbrecht, Martha J. Hart, Sarah Dewell, A. P. Jason de Koning · 2021 · Frontiers in Neuroscience
  42. The role of fatty acid-binding protein 5 and 7 on locomotor, anxiety and social behavior: Interaction with NMDA signaling
    Anas Khan, Brittany Richardson, Nicole M. Roeder, John Hamilton, Matthew Marion, Nathan L. Fearby, Olivia White, Yuji Owada, Yoshiteru Kagawa, Panayotis K. Thanos · 2024 · Neuroscience Letters
  43. GABA-cannabinoid interplays in the dorsal hippocampus and basolateral amygdala mediate morphine-induced amnesia
    Khadijeh Alsadat Sharifi, Ameneh Rezayof, Sakineh Alijanpour, Mohammad‐Reza Zarrindast · 2020 · Brain Research Bulletin
  44. Publishers note
    Kexuan Zhang, Panlin Liao, Jin Wen, Zhonghua Hu · 2022 · IBRO Neuroscience Reports
  45. Neuroimaging Evidence for Cannabinoid Modulation of Cognition and Affect in Man
    Sagnik Bhattacharyya, Kyra-Verena Sendt · 2012 · Frontiers in Behavioral Neuroscience
  46. Tripping with Synthetic Cannabinoids (“Spice”): Anecdotal and Experimental Observations in Animals and Man
    Torbjörn U.C. Järbe, Jimit Girish Raghav · 2016 · Current topics in behavioral neurosciences
  47. Oral Thc: Cbd Cannabis Extract in Main Symptoms of Alzheimer Disease: Agitation and Weight Loss
    Beniamino Palmieri, Maria Vadalà · 2022 · Research Square
  48. The Mediterranean Diet as a Source of Bioactive Molecules with Cannabinomimetic Activity in Prevention and Therapy Strategy
    R. Vago, F. Fiorio, F. Trevisani, A. Salonia, F. Montorsi, A. Bettiga · 2022 · Nutrients
  49. Differential expression of the neuronal CB1 cannabinoid receptor in the hippocampus of male Ts65Dn Down syndrome mouse model
    Nadia Di Franco, Guillaume Drutel, Valérie Roullot, Francisca Julio‐Kalajzić, Valérie Lalanne, Agnès Grel, Thierry Lesté-Lasserre, Isabel Matias, Astrid Cannich, Delphine Gonzales et al. · 2022 · Molecular and Cellular Neuroscience
  50. CB1 Receptor Silencing Attenuates Ketamine-Induced Hyperlocomotion Without Compromising Its Antidepressant-Like Effects
    Pedro Henrique Gobira, Jacob LaMar, J. S. Marques, Ariandra Guerini Sartim, Kennia Moura Silveira, Luana Oliveira dos Santos, Gregers Wegener, Francisco Silveira Guimarães, Ken Mackie, Hui‐Chen Lu et al. · 2022 · Cannabis and Cannabinoid Research
  51. Effects of SativexⓇ on cognitive function in patients with multiple sclerosis: A systematic review and meta-analysis
    Igor Dykukha, Ute Essner, Herbert Schreiber, Lina Marie Raithel, Iris‐Katharina Penner · 2022 · Multiple Sclerosis and Related Disorders
  52. The cannabinoid agonist WIN-2 affects acquisition but not consolidation of a spatial information in training and retraining processes: Relation with transcriptional regulation of the endocannabinoid system?
    Tamara Andrea Alarcon Ferreira, Lorena Bianchine Areal, Alice Laschuk Herlinger, K.K. Paiva, Maria Aparecida Cicilini, Cristina Martins-Silva, Rita Gomes Wanderley Pires · 2019 · Behavioural Brain Research
  53. Subchronic effects of ligands of cannabinoid receptors on learning and memory processes of olfactory bulbectomized rats
    Margarita Velikova, Dobrinka Doncheva, Roman E. Tashev · 2020 · Acta Neurobiologiae Experimentalis
  54. Endocannabinoid and neuroplasticity-related changes as susceptibility factors in a rat model of posttraumatic stress disorder
    László Szente, Gyula Y. Balla, Zoltan K. Varga, Blanka Tóth, László Bíró, Zoltan Balogh, Matthew N. Hill, Máté Tóth, Éva Mikics, Manó Aliczki · 2024 · Neurobiology of Stress
  55. Fructose diet ameliorates effects of macrophage migration inhibitory factor deficiency on prefrontal cortex inflammation, neural plasticity, and behavior in male mice
    Miloš Vratarić, Vladimir Šenk, Biljana N. Bursać, Ljupka Gligorovska, Đurđica Ignjatović, Sanja Kovačević, Nataša A. Veličković, Ana D. Djordjevic · 2021 · BioFactors
  56. Effects of cannabinoid exposure on short-term memory and medial orbitofrontal cortex function and chemistry in adolescent female rhesus macaques
    Stephen John Kohut, Lei Cao, Dionyssios Mintzopolous, Shan Jiang, Spyros P. Nikas, Alexandros Makriyannis, Chun S. Zou, John Eric Jensen, Blaise B. Frederick, Jack Bergman et al. · 2022 · Frontiers in Neuroscience
  57. The Effects of Echinacea (EP107TM) on Anxiety: A Comparison of Anxiety Measures in a Randomized, Double Blind, Placebo-Controlled Study
    József Haller, Gábor Faludi, Kovacs Gábor, György Purebl, Zoltán Füzesi, Tamás F. Freund · 2025 · Pharmaceuticals
  58. Prenatal alcohol exposure dysregulates the expression of clock genes and alters rhythmic behaviour in mice
    Maria Reina-Campos, Inés Gallego‐Landin, Mireia Medrano, Alba García-Baos, Olga Valverde · 2025 · Open Biology
  59. Essential fatty acids and lipid mediators. Endocannabinoids
    Giuseppe Caramia · 2012 · La Pediatria Medica e Chirurgica
  60. The Neurochemistry of Social Play Behaviour in Rats
    Viviana Trezza, E. J. Marijke Achterberg, Louk J. M. J. Vanderschuren · 2018 · Cambridge University Press eBooks
  61. Interactions Between Cannabinoid Signaling and Anxiety: A Comparative Analysis of Intervention Tools and Behavioral Effects
    Manó Aliczki, József Haller · 2015 · Springer eBooks
  62. Cannabinoid type-1 receptors in CaMKII neurons drive impulsivity in pathological eating behavior
    Elena Martín‐García, Laura Domingo‐Rodriguez, Beat Lutz, Rafael J. Maldonado, Iñigo Ruı́z de Azúa · 2025 · Molecular Metabolism
  63. Pharmacological characterization of a new synthesis compound with antagonistic action on CB1 receptors: Evidence from the animal experimental model
    Fabiana Plescia, Gianluca Lavanco, Maria Grazia Zizzo, Cesare D'Amico, Luigi Bellocchio, Ginevra Malta, Francesca Vaccaro, Emanuele Cannizzaro, Leila Dimino, Fulvio Plescia · 2025 · European Journal of Pharmacology
  64. Endocannabinoid system in trauma and psychosis: distant guardian of mental stability
    Tomasz Bielawski, Lucas Albrechet‐Souza, Dorota Frydecka · 2021 · Reviews in the Neurosciences
  65. Sub‐chronic administration of AM6545 enhances cognitive performance and induces hippocampal synaptic plasticity changes in naïve mice
    Araceli Bergadà‐Martínez, Lucía de los Reyes‐Ramírez, Sara Martínez‐Torres, Laura Ciaran‐Alfano, Irene Martínez‐Gallego, Rafael J. Maldonado, Antonio Rodríguez Moreno, Andrés Ozaita · 2025 · British Journal of Pharmacology
  66. The long-term effects of Δ9-tetrahydrocannabinol on microtubule dynamicity in rats
    Dariush Gholami, Ali Reza Noori, Mina Mohammadkhani, Zeinab Emruzi, Gholam Hossein Riazi · 2020 · Archives of Biochemistry and Biophysics
  67. Innovative Clinical-Organizational Model to Ensure Appropriateness and Quality in the Management of Medical Cannabis: An Italian Regional Case
    Eleonora Russo, Clara Cannas, Maria Susanna Rivetti, Carla Villa, Barbara Rebesco · 2021 · Healthcare
  68. The effects of adolescent cannabinoid exposure on seizure susceptibility and lethality in adult male rats
    Mitchell G. Spring, Kathleen D. Schoolcraft, Hassan H. López · 2015 · Neurotoxicology and Teratology
  69. Cannabinoids: Drug or Medication?
    Léa Giron, Katia Befort · 2016 · InTech eBooks
  70. Preventive effect of N-stearoylethanolamine on memory disorders, blood and brain biochemical parameters in rats with experimental scopolamine-induced cognitive impairment
    Horid'ko Tm, Halyna V. Kosiakova, Berdyshev Ah · 2018 · The Ukrainian Biochemical Journal
  71. The endocannabinoid system: a key modulator of emotions and cognition
    2013 · Frontiers research topics
  72. Zebrafish as a High-Throughput In Vivo Model for Testing the Bioactivity of Cannabinoids
    Lee Ellis · 2019 · IntechOpen eBooks
  73. Reduced CB1 Cannabinoid Receptor Expression in Alzheimer's Disease and Transgenic Mouse Models
    Nike von Borcke, Amrei Vivian Purwien, Annik Steiert, Henrike Hasecke, Yvonne Bouter · 2026 · Aging Medicine
  74. Activation of the endocannabinoid system in schizophrenia: A compensatory mechanism of subclinical inflammation?
    Błażej Misiak, Tomasz Bielawski, Jerzy Samochowiec, Agnieszka Samochowiec, Mariusz G. Fleszar, Paulina Fortuna, Bogna Kosyk, Dorota Frydecka · 2023 · Schizophrenia Research
  75. Exercise, the endocannabinoid system and metabolic health
    Petri Wiklund, Satu Pekkala, Sulin Cheng · 2013 · Journal of sport and health science/Journal of Sport and Health Science
  76. Cannabiskonsum zum Freizeitgebrauch
    Miriam Schneider, Chris M. Friemel, Rupert von Keller, Kristina Adorjan, Udo Bonnet, Alkomiet Hasan, Derik Hermann, Joseph Kambeitz, Dagmar Koethe, Ludwig Kraus et al. · 2018 · Springer eBooks
  77. Cannabinoids Modulation of Emotional and Non-Emotional Memory Processes After Stress
    Irit Akirav, Anna Portugalov · 2015 · Springer eBooks
  78. Considering the Effects of Cannabinoids and Exercise on the Brain: A Narrative Review
    Amir Yahya Rajaei, J. Patrick Neary, Elizabeth S. Thompson, Jyotpal Singh, Cameron S. Mang · 2025 · Sports
  79. Therapeutic potential of cannabidiol and its underlying mechanisms
    Masahito Watanabe, Hana Hayasaki, Yuko Yurugi, Katsuya Watanabe · 2018 · Journal of allied health sciences
  80. Brain PET Poster Sessions PP01-M01 to PP02-N07
    D. Lange, Isabel Martinez Tejada, M. xiong, B. Hillebrand, M. Noergaard, S. Baerentzen, Vladimir Shalgunov, M. M. Herth, C. Svarer, M. Palner · 2019 · Journal of Cerebral Blood Flow & Metabolism
  81. A „bika drog” rendészeti neurobiológiája
    Éva Rompos, Noémi Emőke Baráth, Mária Zsóka Bellavics, Klaudia Lohner, József Haller · 2021 · Belügyi Szemle
  82. Assessment of Potential Long Term Health Effects on Army Human Test Subjects of Relevant Biological and Chemical Agents, Drugs, Medications and Substances
    Kelli Johnson · 2016 · Defense Technical Information Center (DTIC)
  83. Neuropharmacology of Cannabinoids
    Miriam Schneider, Maurice R. Elphick · 2013 · Elsevier eBooks
  84. Endocannabinoid Modulation of Memory for Emotionally Arousing Experiences
    Maria Morena, Federica Mariani, Eleni Papagianni, Patrizia Campolongo · 2015 · Springer eBooks
  85. Functional Autoradiography as a Pharmacological Approach for Studying G Protein-Coupled Lipid Receptor Signalling
    Niina Aaltonen · 2013 · UEF eRepo (University of Eastern Finland)
  86. Training-AssociatedEmotionalArousalShapes EndocannabinoidModulationofSpatialMemoryRetrieval inRats
    J. MeganGray · 2015
  87. Contributions to the epidemiology and mental health consequences of cannabis smoking
    Brian J. Fairman · 2014 · Michigan State University Libraries
  88. Neurobiological substrates involved in the behavioural alterations induced by MDMA and THC administration in mice
    Viñals Álvarez, Xavier · 2015 · TDX (Tesis Doctorals en Xarxa)
  89. Metabolism and Action of Polyunsaturated N-acylethanolamines in Arabidopsis thaliana Seedlings
    Jantana Keereetaweep · 2015 · University of North Texas Digital Library (University of North Texas)
  90. Article Open Access
    Holly Lawford‐Smith · 2015
  91. ENDOCANNABINOID REGULATION OF ADOLESCENT DEVELOPMENT IN MALE AND FEMALE RATS
    Jonathan J. Simone · 2018 · Brock University Digital Repository (Brock University)
  92. Kannabinoid 1-es receptor gátló szerek in vivo farmakológiai jellemzése különös tekintettel a szorongáskeltő hatásokra
    Varga, Balázs · 2017 · Eötvös Loránd Tudományegyetem
  93. Novel Biological Treatment Strategies
    G. Paul Amminger, Maximus Berger · 2019 · Cambridge University Press eBooks
  94. Cannabinoid and Marijuana Neurobiology
    Bertha Kalifon Madras · 2020 · Springer eBooks
  95. Peripheral CB1 receptor blockade acts as a memory enhancer through an adrenergic-dependent mechanism
    Sara Martínez‐Torres, Araceli Bergadà‐Martínez, Jorge Emilio Ortega, Lorena Galera-López, Arnau Hervera, Antonio Ortega-Álvaro, Floortje Remmers, Emma Muñoz‐Moreno, Guadalupe Sòria, José Antonio del Rı́o et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  96. Cognitive Deficiency in Cannabis Consumers
    Wurgan Rahadian, Abraham Sabda Respati, Supra Wimbarti, Sri Koesrohmaniah · 2021 · Buletin Psikologi
  97. The highs and lows of drugs use: acute effects of cannabis, cocaine and MDMA on impulsivity, cognition and subjective experience
    Janelle H. P. van Wel · 2014 · Research Publications (Maastricht University)
  98. WIRELESS INFRASTRUCTURE: THE ROAD MAP TO HIGH DATA RATES.
    Mats Nilsson, Lars J Nilsson · 2000
  99. MODERN VIEW OF CANNABIS AND ITS INFLUENCE ON THE BODY
    С. В. Бабак, B. A. Kabrera-Lapitska · 2022 · Bulletin of Problems Biology and Medicine
  100. Faculty Opinions recommendation of Dissociation of the pharmacological effects of THC by mTOR blockade.
    Dave Nichols · 2013 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature